Decibel Bio
Venture Round in 2025
Decibel Bio is a plant biotechnology company that develops a crop epigenetic platform. This platform provides farmers with precise, in-season information about foliar sprays or seed treatments, enabling them to predict crop traits and agronomic outcomes more accurately than traditional methods. By using this platform, growers can enhance nutrient uptake and boost stress tolerance in plants, adapting to varying weather and market conditions.
Molten Salt Solutions
Seed Round in 2024
Molten Salt Solutions develops a technology platform to commercialize molten salt synthesis and purification and to advance isotope enrichment for nuclear power. The platform includes proprietary chromatography and mass spectrometry systems along with metal salt synthesis methods, enabling safer, more cost-efficient production of isotopically enriched materials for both fission and fusion applications. The company was founded in 2018 and is headquartered in Santa Fe, New Mexico.
Hephae Energy Technology
Venture Round in 2024
Hephae Energy Technology develops an integrated drilling system that enables the safe, efficient, and cost‑effective extraction of geothermal energy. The company’s technology harnesses abundant heat resources worldwide, providing a new generation of drilling solutions that improve accuracy, safety, and productivity for geothermal wells.
Vironexis Biotherapeutics
Seed Round in 2024
Vironexis Biotherapeutics is a biotechnology company focused on advancing immunotherapy for cancer treatment. The company specializes in AAV-delivered T-cell immunotherapy, utilizing a gene therapy platform that facilitates the development of off-the-shelf, single-dose gene therapies. This innovative approach aims to enhance patient outcomes by enabling healthcare professionals to leverage T-cell-mediated mechanisms for more effective cancer treatment. With its commitment to transforming the landscape of immunotherapy, Vironexis is positioned to make significant contributions to the future of cancer care.
Earthshot Labs
Venture Round in 2024
Earthshot Labs is a developer of a climate mitigation platform focused on ecological restoration on a global scale. The company utilizes an AI-powered platform to connect investors, carbon buyers, and land stewards, facilitating the financing of projects that promote ecological restoration while ensuring equity for local communities. Its comprehensive tool allows users to algorithmically identify specific regenerative strategies tailored to individual land parcels, ultimately enabling clients to maximize both the natural and economic potential of their land. Through its innovative approach, Earthshot Labs aims to enhance ecosystem regeneration and contribute to climate solutions worldwide.
Xona Space Systems
Series A in 2024
Xona Space Systems develops and manufactures position, navigation, and timing satellite solutions for smart transportation and infrastructure. The company operates a constellation of low-cost, low-Earth-orbit satellites to deliver secure navigation and timing services with resilience and high location precision for autonomous vehicles, unmanned aerial vehicles, mobile robotics, and other location-critical applications. Founded in 2019 and based in San Mateo, California, Xona Space Systems aims to enable safe, scalable operation of intelligent systems at scale.
Glass Imaging
Seed Round in 2024
Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.
Moonwalk Biosciences
Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.
Woola designs and produces sustainable packaging materials using upcycled sheep wool as cushioning to replace bubble wrap. The products provide shock absorption, thermal resistance, and can be reused, repurposed, or returned by end users to support a closed-loop system and reduce plastic usage. The materials come in modular sheet and envelope formats, enabling retailers and e-commerce brands to protect delicate goods during shipping while minimizing waste.
Amplifier Therapeutics
Series A in 2023
Amplifier Therapeutics is a biopharmaceutical company dedicated to developing novel therapies targeting AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance. The company's focus is on treating age-related disorders, including metabolic conditions, cardiovascular diseases, kidney diseases, and certain types of cancer, by activating AMPK to restore normal cellular function.
Lace Lithography
Seed Round in 2023
Lace Lithography is a technology company specializing in the development of advanced lithography solutions for semiconductor manufacturing. Their core innovation lies in a chip patterning technology that replaces traditional light-based methods with atomic-scale precision, enabling the production of smaller, more efficient chips. This breakthrough extends the limits of Moore's Law, allowing industries to continue advancing semiconductor technology in a cost-effective and energy-efficient manner.
Robust.AI
Series A in 2023
Robust.AI develops autonomous mobile robots and AI-powered software for warehouse and manufacturing operations. The company combines artificial intelligence, robotics, and human-centered design through its Grace software suite and Carter hardware concept, enabling rapid deployment with minimal infrastructure changes, scalable operations, and support for dynamic material handling tasks. Its solutions target warehousing environments where automation is still limited and labor shortages affect supply chains, aiming to improve interaction between people and robots and to streamline workflows.
OutcomeMD
Convertible Note in 2022
OutcomeMD is a Los Angeles-based provider of an outcomes management platform that scores and tracks patient-reported outcomes across medical specialties via a SaaS solution. The platform enables real-time outcome tracking, seamless electronic health record integration, and support for PROMIS and disease-specific measures, helping clinicians identify clinical risks early, enhance patient engagement, and deliver more effective care. By aggregating outcomes data into regular workflows, OutcomeMD supports objective demonstration of treatment efficacy and improves clinical efficiency.
Verdant Robotics
Series A in 2022
Verdant Robotics, Inc., founded in 2018 and based in Hayward, California, specializes in artificial intelligence-driven robotic solutions for agriculture. The company develops advanced technologies that enable farmers to digitally map their fields and monitor each plant's health over time. Verdant's flagship product, the Model B Smart Sprayer, significantly reduces labor costs by over 50% and input costs by up to 96% while providing precise weeding and thinning for various crop types. Utilizing proprietary Bullseye targeting technology and a Pinpoint Spray System, Verdant promotes micro-fertilization and nutrient delivery, enhancing crop yields and efficiency. By leveraging robotics, computer vision, and machine learning, Verdant Robotics empowers growers of all sizes to optimize production and improve profitability in the agricultural sector.
Enriched Ag
Seed Round in 2022
Enriched Ag enhances agricultural resilience and profitability through its data-driven insights platform. This platform predicts weather patterns, forage plans, grazing rotations, and provides life cycle assessment GHG estimates for beef production, processing, and transportation.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
YourChoice Therapeutics
Series A in 2022
YourChoice Therapeutics, Inc. is a biotechnology company based in Berkeley, California, founded in 2018. The company focuses on developing non-hormonal contraceptive products aimed at providing women with safe and effective birth control options. Its innovative technology is based on the concept of a "molecular condom," which utilizes an active compound to inhibit sperm motility, thereby preventing sperm from fertilizing the egg. This approach seeks to eliminate the risks and side effects commonly associated with traditional hormonal contraceptive methods, offering a promising alternative for those seeking safer birth control solutions.
Faeth Therapeutics
Series A in 2022
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.
ALICE Technologies
Series B in 2022
ALICE Technologies develops an AI-powered construction simulation platform. It uses artificial intelligence to analyze complex building requirements, generate efficient schedules, and optimize them during construction. The platform helps contractors and owners plan, bid, and build more effectively, potentially saving millions in labor costs.
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.
64x Bio develops a platform that accelerates and scales mammalian cell line discovery. It combines high-throughput screening with computational design loops to create optimized cell lines for viral vector production, focusing on those used in cell and gene therapies.
Faeth Therapeutics
Seed Round in 2022
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
Ockam Inc. provides a serverless platform for secure Internet-of-things (IoT) development. Its tool enables hardware-to-software interconnection, facilitates information exchange within connected systems, manages identities and cryptographic keys, optimizes connectivity, and connects application developers, engineers, and product managers.
Woola designs and produces sustainable packaging materials using upcycled sheep wool as cushioning to replace bubble wrap. The products provide shock absorption, thermal resistance, and can be reused, repurposed, or returned by end users to support a closed-loop system and reduce plastic usage. The materials come in modular sheet and envelope formats, enabling retailers and e-commerce brands to protect delicate goods during shipping while minimizing waste.
New Culture
Series A in 2021
Founded in 2018, New Culture is a food company based in San Francisco, California. It specializes in producing sustainable, animal-free cheese using microflora to create dairy proteins.
Cambrian BioPharma
Series C in 2021
Cambrian BioPharma specializes in developing innovative therapeutics aimed at extending healthspan, the period of life spent in good health. As a Distributed Development Company (DisCo), it focuses on advancing scientific breakthroughs targeting biological drivers of aging, initially treating specific diseases and later deploying these interventions preventatively to enhance overall quality of life.
MosaicML
Venture Round in 2021
MosaicML is a company focused on creating an efficient infrastructure for training large language models and improving the overall efficiency of neural networks. It develops software and artificial intelligence training algorithms that enhance the training process by utilizing algorithmic techniques such as sparsity and network pruning. These innovations allow users to effectively and securely train large-scale AI models on their proprietary data, while also optimizing for speed, quality, and cost. MosaicML aims to streamline the machine learning model recomposition process, making it easier for organizations to harness the power of AI in their operations.
Earthshot Labs
Seed Round in 2021
Earthshot Labs is a developer of a climate mitigation platform focused on ecological restoration on a global scale. The company utilizes an AI-powered platform to connect investors, carbon buyers, and land stewards, facilitating the financing of projects that promote ecological restoration while ensuring equity for local communities. Its comprehensive tool allows users to algorithmically identify specific regenerative strategies tailored to individual land parcels, ultimately enabling clients to maximize both the natural and economic potential of their land. Through its innovative approach, Earthshot Labs aims to enhance ecosystem regeneration and contribute to climate solutions worldwide.
Hum Capital
Series A in 2021
Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.
Latent AI
Series A in 2021
Founded in 2018, Latent AI develops a platform that enables smart Internet of Things (IoT) applications by optimizing AI neural networks for edge devices. Its LEIP platform allows developers to train, quantize, and deploy edge AI neural networks cost-effectively across the edge continuum.
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.
Beeflow is a biotechnology-driven company that applies science and technology to bee pollination. The company provides professional pollination services to farmers, leveraging proprietary pollination technologies, data-driven hive management, and expertise in bee biology and crop science to optimize pollination and improve crop quality for crops such as blueberries, almonds, raspberries, and kiwifruit. Operating in the United States, Peru, and Mexico, Beeflow began in Argentina and has expanded to international markets, aiming to increase crop yields while supporting bee health and sustainability.
MobileCoin
Series A in 2021
MobileCoin, established in 2017 and headquartered in San Francisco, specializes in developing a cryptocurrency focused on privacy and security for peer-to-peer transactions. Its blockchain-based product aims to facilitate seamless mobile payments by enabling integration with popular messaging platforms like WhatsApp or Signal.
Cambrian BioPharma
Series B in 2021
Cambrian BioPharma specializes in developing innovative therapeutics aimed at extending healthspan, the period of life spent in good health. As a Distributed Development Company (DisCo), it focuses on advancing scientific breakthroughs targeting biological drivers of aging, initially treating specific diseases and later deploying these interventions preventatively to enhance overall quality of life.
Sensei Biotherapeutics
Series B in 2021
Sensei Biotherapeutics is a clinical-stage biotechnology company developing next-generation cancer immunotherapies. It focuses on novel biologics that modulate the immune system to treat cancers with unmet need, using its ImmunoPhage discovery platform to study the tumor microenvironment and identify differentiated mechanisms that engage both innate and adaptive immunity. The company pursues a Tumor Microenvironment Activated Biologics TMAb platform to selectively disable immunosuppressive signals or activate immunostimulatory signals within the tumor microenvironment. Headquartered in Gaithersburg, Maryland with an office in Boston, Massachusetts, Sensei Biotherapeutics has four investigational product candidates in development: SNS-101, SNS-102, SNS-103, and SNS-201.
ATAI Life Sciences
Series C in 2020
ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.
ALICE Technologies
Debt Financing in 2020
ALICE Technologies develops an AI-powered construction simulation platform. It uses artificial intelligence to analyze complex building requirements, generate efficient schedules, and optimize them during construction. The platform helps contractors and owners plan, bid, and build more effectively, potentially saving millions in labor costs.
Sensei Biotherapeutics
Series A in 2020
Sensei Biotherapeutics is a clinical-stage biotechnology company developing next-generation cancer immunotherapies. It focuses on novel biologics that modulate the immune system to treat cancers with unmet need, using its ImmunoPhage discovery platform to study the tumor microenvironment and identify differentiated mechanisms that engage both innate and adaptive immunity. The company pursues a Tumor Microenvironment Activated Biologics TMAb platform to selectively disable immunosuppressive signals or activate immunostimulatory signals within the tumor microenvironment. Headquartered in Gaithersburg, Maryland with an office in Boston, Massachusetts, Sensei Biotherapeutics has four investigational product candidates in development: SNS-101, SNS-102, SNS-103, and SNS-201.
Taimei Technology
Venture Round in 2020
Taimei Technology is a digital innovator specializing in research and development within the life science industry. The company offers an integrated digital platform that leverages AI, big data, cloud computing, and mobile internet technologies to provide innovative solutions across the full product lifecycle.
Hum Capital
Seed Round in 2020
Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.
Commonwealth Fusion
Series A in 2020
Founded in 2017, Commonwealth Fusion is a research company developing fusion energy through an inexhaustible power plant. It combines proven physics with revolutionary superconducting magnet technology to accelerate the path to commercial fusion energy.
Deep Genomics
Series B in 2020
Deep Genomics is a Toronto-based company founded in 2014. It specializes in developing individualized genetic medicines using artificial intelligence systems to accelerate drug discovery and development processes, including target discovery, lead optimization, toxicity assessment, and innovative trial design. The company focuses on therapies for rare metabolic, ophthalmologic, and neurodegenerative disorders, utilizing oligonucleotide therapies that target genetic determinants of disease at the RNA or DNA level.
Enriched Ag
Pre Seed Round in 2020
Enriched Ag enhances agricultural resilience and profitability through its data-driven insights platform. This platform predicts weather patterns, forage plans, grazing rotations, and provides life cycle assessment GHG estimates for beef production, processing, and transportation.
Hum Capital
Seed Round in 2019
Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.
Ockam Inc. provides a serverless platform for secure Internet-of-things (IoT) development. Its tool enables hardware-to-software interconnection, facilitates information exchange within connected systems, manages identities and cryptographic keys, optimizes connectivity, and connects application developers, engineers, and product managers.
The Boring Company
Venture Round in 2019
The Boring Company is an infrastructure and tunnel construction company focused on developing underground transportation networks. It designs and builds tunnel systems to alleviate urban traffic, offering safe, fast, and cost-efficient routes for transportation, utilities, and freight, with the aim of reducing surface congestion and expanding mobility options.
Commonwealth Fusion
Series A in 2019
Founded in 2017, Commonwealth Fusion is a research company developing fusion energy through an inexhaustible power plant. It combines proven physics with revolutionary superconducting magnet technology to accelerate the path to commercial fusion energy.
Latent AI
Seed Round in 2019
Founded in 2018, Latent AI develops a platform that enables smart Internet of Things (IoT) applications by optimizing AI neural networks for edge devices. Its LEIP platform allows developers to train, quantize, and deploy edge AI neural networks cost-effectively across the edge continuum.
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Medcorder
Seed Round in 2019
Medcorder, Inc. is a technology company that has developed a mobile application aimed at enhancing communication and care coordination between patients, their families, and healthcare providers. Founded in 2019 and based in Redwood City, California, the Medcorder app allows users to record and transcribe conversations with their doctors, facilitating better understanding and retention of medical information. This functionality is particularly beneficial for patients with complex health conditions, as it supports the involvement of family members, even those who are geographically distant. By streamlining communication and reducing the need for repeated medical consultations, Medcorder aims to improve patient outcomes through better-informed decision-making and more efficient care management. The application is compatible with both Android and iOS devices, making it accessible to a wide audience.
Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.